
The Center for American Principles submitted a public comment to the Office of the United States Trade Representative (USTR) supporting its Section 301 investigation into Germany’s compulsory pharmaceutical pricing[…]

The Center for American Principles submitted a letter to the Senate Judiciary Committee ahead of its July 14 hearing, “From Genes to Machines: the Patent Eligibility Debate,” urging lawmakers[…]

Center for American Principles Policy Fellow Patrick Kilbride recently joined the IP Protection Matters podcast to discuss the U.S. Trade Representative’s 2026 Special 301 Report and the importance of[…]

The Center for American Principles submitted a letter to the Senate Committee on Health, Education, Labor & Pensions (HELP) ahead of its June 17 business meeting, urging lawmakers to[…]

Center for American Principles Policy Fellow Patrick Kilbride recently published an Op-Ed in IPWatchdog on the importance of patents to America’s biopharmaceutical innovation ecosystem. Kilbride writes that strong patent[…]

The Center for American Principles’ latest Issue Brief, Biopharmaceutical Patents, explains how patent protections fuel medical innovation and enable the development of life-saving therapies. The brief outlines how patents[…]

The Center for American Principles released a statement from President Tony Zagotta in response to the White House announcement that it will exercise its authority under Section 232 of[…]

CAP President Anthony Zagotta attended the Southwest Florida Center-Right meeting on March 20th, 2026. Rep. Yvette Benarroch gave us an update on legislation passed in this session.

“For far too long, wealthy nations such as Japan have benefited from American medical innovation while implementing costly price controls on medications that result in higher prices for U.S.[…]

The Center for American Principles submitted a formal public comment to the Centers for Medicare & Medicaid Services (CMS) opposing the proposed “Global Benchmark for Efficient Drug Pricing” (GLOBE)[…]

The Center for American Principles submitted a formal public comment to the Centers for Medicare & Medicaid Services (CMS) opposing the proposed “Guarding U.S. Medicare Against Rising Drug Costs”[…]

The Center for American Principles joined more than 50 free-market groups and policy advocates in opposing the codification of a Most-Favored-Nation (MFN) drug pricing framework, as highlighted in a[…]

The Center for American Principles joined more than 50 conservative leaders and free-market organizations in signing a coalition letter opposing efforts to codify a Most-Favored-Nation (MFN) drug pricing model.[…]

The Center for American Principles joined a coalition of 43 organizations urging Congress to adopt a temporary federal preemption of certain state-level artificial intelligence laws while a comprehensive national[…]

Center for American Principles President Anthony Zagotta recently posted an Op-Ed in The Well News on Real Health Care Reform Starts with Taking on Insurers. Congressional Republicans are considering[…]